Index sorted by Drug, Company, and Foundations and Nonprofit/Government Organizations

Support Services Directory

Recent advancements in cancer treatments have revolutionized cancer care. The use of genetic mutations to guide therapy, and continued innovations in immunotherapies, targeted drugs, radiation, and chemotherapy have improved patients’ health outcomes and quality of life.

AbbVie’s Venclexta Access Solutions

AbbVie, together with Genentech, has developed and is marketing the oncology drug Venclexta (venetoclax). Venclexta is indicated for patients with chronic lymphocytic leukemia and 17p deletion who have received at least 1 treatment, and for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma with or without 17p deletion after 1 treatment.

Amgen Assist 360/FIRST STEP Program

Amgen Assist 360 provides several support services for insured, uninsured, and underinsured patients who encounter financial hardships and cannot afford the Amgen medications they are prescribed, including Amgen FIRST STEP and the Amgen Safety Net Foundation.

ArrayACTS Patient Support Programs

Array BioPharma, via its ArrayACTS patient support program, offers several financial assistance options and support services for patients who have been prescribed the combination of Braftovi (encorafenib) and Mektovi (binimetinib) but who cannot afford to pay for them.

Astellas Xtandi Support Solutions

Astellas Pharma’s Xtandi Support Solutions offers patient assistance services to eligible patients who are prescribed Xtandi (enza­lutamide) for the treatment of castration-resistant prostate cancer (CRPC) or for metastatic CRPC.